Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1

被引:121
作者
Ambrosino, G
Varotto, S
Strom, SC
Guariso, G
Franchin, E
Miotto, D
Caenazzo, L
Basso, S
Carraro, P
Valente, ML
D'Amico, D
Zancan, L
D'Antiga, L
机构
[1] Univ Padua, Dept Paediat, I-35128 Padua, Italy
[2] Univ Padua, Dept Surg & Gastroenterol Sci, I-35128 Padua, Italy
[3] Univ Padua, Dept Lab Med, I-35128 Padua, Italy
[4] Univ Padua, Dept Radiol, I-35128 Padua, Italy
[5] Univ Padua, Dept Environm Med & Publ Hlth, I-35128 Padua, Italy
[6] Univ Padua, Dept Pathol, I-35128 Padua, Italy
[7] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
关键词
hepatocyte transplantation; Crigler-Najjar syndrome; uridine diphosphoglucuronate glucuronosyltransferase; enzyme replacement therapy;
D O I
10.3727/000000005783983250
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Crigler-Najjar syndrome type 1 (CN1) is an inherited disorder characterized by the absence of hepatic uridine diphosphoglucuronate glucuronosyltransferase (UDPGT), the enzyme responsible for the conjugation and excretion of bilirubin. We performed allogenic hepatocyte transplantation (AHT) in a child with CN1, aiming to improve bilirubin glucuronidation in this condition. A 9-year-old boy with CN1 was prepared with plasmapheresis and immunosuppression with prednisolone and tacrolimus. When a graft was made available, 7.5 x 10(9) hepatocytes were isolated and infused into the portal vein percutancously. After 2 weeks phenobarbitone was added to promote the enzymatic activity of UDPGT of the transplanted hepatocytes. Nocturnal phototherapy was continued throughout the studied period. Total bilirubin was considered a reliable marker of allogenic cell function. There was no significant variation of vital signs nor complications during the infusion. Mean +/- SD bilirubin level was 530 +/- 38 mu mol/L before and 359 46 mu mol/L after AHT (t-test, p < 0.001). However, the introduction of phenobarbitone was followed by a drop of tacrolimus level with increase of alanine aminotransferase (ALT) and increase of bilirubin. After standard treatment of cellular rejection bilirubin fell again but from then on it was maintained at a greater level. After discharge the patient experienced a further increase of bilirubin that returned to predischarge levels after readmission to the hospital. This was interpreted as poor compliance with phototherapy. Only partial correction of clinical jaundice and the poor tolerability to nocturnal phototherapy led the parents to refuse further hepatocyte infusions and request an orthotopic liver transplant. After 24 months the child is well, with good liver function on tacrolimus and prednisolone-based immunosuppression. Isolated AHT, though effective and safe, is not sufficient to correct CN1. Maintenance of adequate immunosuppression and family compliance are the main factors hampering the success of this procedure.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 22 条
  • [1] Hepatocyte transplantation in the treatment of acute liver failure: Microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix
    Ambrosino, G
    Varotto, S
    Basso, SMM
    Cecchetto, A
    Carraro, P
    Naso, A
    De Silvestro, G
    Plebani, M
    Abatangelo, G
    Donato, D
    Cestrone, A
    Giron, G
    D'Amico, DF
    [J]. CELL TRANSPLANTATION, 2003, 12 (01) : 43 - 49
  • [2] Asher D M, 1999, Dev Biol Stand, V100, P103
  • [3] PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD-STORAGE
    BELZER, FO
    SOUTHARD, JH
    [J]. TRANSPLANTATION, 1988, 45 (04) : 673 - 676
  • [4] CHOWDHURY NR, 2001, LIVER BIOL PATHOBIOL, P291
  • [5] CRIGLER JF, 1952, PEDIATRICS, V10, P169
  • [6] Late cellular rejection in paediatric liver transplantation: Aetiology and outcome
    D'Antiga, L
    Dhawan, A
    Portmann, B
    Francavilla, R
    Rela, M
    Heaton, N
    Mieli-Vergani, G
    [J]. TRANSPLANTATION, 2002, 73 (01) : 80 - 84
  • [7] CONDITIONAL IMMORTALIZATION OF GUNN RAT HEPATOCYTES - AN EX-VIVO MODEL FOR EVALUATING METHODS FOR BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE GENE-TRANSFER
    FOX, IJ
    CHOWDHURY, NR
    GUPTA, S
    KONDAPALLI, R
    SCHILSKY, ML
    STOCKERT, RJ
    CHOWDHURY, JR
    [J]. HEPATOLOGY, 1995, 21 (03) : 837 - 846
  • [8] Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation
    Fox, IJ
    Chowdhury, JR
    Kaufman, SS
    Goertzen, TC
    Chowdhury, NR
    Warkentin, PI
    Dorko, K
    Sauter, BV
    Strom, SC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) : 1422 - 1426
  • [9] Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder
    Horslen, SP
    McCowan, TC
    Goertzen, TC
    Warkentin, PI
    Cai, HB
    Strom, SC
    Fox, IJ
    [J]. PEDIATRICS, 2003, 111 (06) : 1262 - 1267
  • [10] ORTHOTOPIC LIVER-TRANSPLANTATION FOR TYPE-I CRIGLER-NAJJAR SYNDROME
    KAUFMAN, SS
    WOOD, RP
    SHAW, BW
    MARKIN, RS
    ROSENTHAL, P
    GRIDELLI, B
    VANDERHOOF, JA
    [J]. HEPATOLOGY, 1986, 6 (06) : 1259 - 1262